| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| senktide | integrin alpha-4 | NA | Successful target | TTD , DGIDB | Cerebrovascular accident[MeSHID:D020521] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Epilepsy[MeSHID:D004827] |
5.3 | phase 2 | unknown |
| senktide | neuromedin-k receptor | NA | Clinical trial target | TTD , DGIDB | Cerebrovascular accident[MeSHID:D020521] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Epilepsy[MeSHID:D004827] |
5.79 | phase 2 | agonist |
| senktide | neuromedin-k receptor | NA | Clinical trial target | TTD , DGIDB | Cerebrovascular accident[MeSHID:D020521] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Epilepsy[MeSHID:D004827] |
5.79 | phase 2 | unknown |
| click here to return to the previous page | ||||||||